Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.35 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.35 |
| ▸ | CYP26B1 | Q9NR63 | 1/20 | 0.34 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
| ▸ | FABP4 | P15090 | 4/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.33 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.33 |
| ▸ | APEX1 | P27695 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13264906 | 0.99 | CYP26B1 (0.35) | ALDH1A1TBXA2RCYP26B1PKMFABP4 | |
| SCHEMBL2721464 | 0.98 | P2RX3 (0.35) | ALDH1A1TBXA2RCYP26B1PKMFABP4 | |
| SCHEMBL15628865 | 0.95 | CYP26B1 (0.36) | ALDH1A1TBXA2RCYP26B1PKMFABP4 | |
| SCHEMBL2721462 | 0.90 | CYP26B1 (0.34) | ALDH1A1TBXA2RCYP26B1PKMFABP4 | |
| SCHEMBL10090477 | 0.88 | ALDH1A1 (0.35) | ALDH1A1S1PR3GAA | |
| SCHEMBL560019 | 0.87 | CA2 (0.31) | S1PR3 | |
| SCHEMBL18386292 | 0.87 | ALDH1A1 (0.37) | ALDH1A1MAPK1S1PR3GAATBXAS1 | |
| SCHEMBL13264903 | 0.86 | ALDH1A1 (0.36) | ALDH1A1GAA | |
| SCHEMBL17119895 | 0.86 | MEN1 (0.33) | ALDH1A1TBXA2RPKMFABP4MAPK1 | |
| SCHEMBL7602622 | 0.85 | ALDH1A1 (0.40) | ALDH1A1FABP4MAPK1APEX1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 124 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070178511-A1 | MODIFIED CARBOCYANINE DYES AND THEIR CONJUGATES | INVITROGEN CORPORATION (US) | 2007-08-02 | — | — | US | claimed |
| US-20230270890-A1 | FLUORESCENT COMPOUND FOR DETECTING BIOLOGICAL MATERIAL AND PREPARATION METHOD THEREOF | BIOACTS CORPORATION (KR) | 2023-08-31 | — | — | US | disclosed |
| US-11597842-B2 | Labeling dye and kit including same | SFC CO., LTD. (KR) | 2023-03-07 | — | — | US | disclosed |
| EP-2618849-B1 | MULTIVALENT FLUORESCENT PROBES | CALIPER LIFE SCIENCES INC (US) | 2020-10-21 | — | — | EP | disclosed |
| US-20200255668-A1 | LABELING DYE AND KIT INCLUDING SAME | SFC CO., LTD. (KR) | 2020-08-13 | — | — | US | disclosed |
| US-10294204-B2 | Fluorescence compounds and preparation method thereof | BIOACTS CO., LTD. (KR) | 2019-05-21 | — | — | US | disclosed |
| US-20170313883-A1 | FLUORESCENCE COMPOUNDS AND PREPARATION METHOD THEREOF | BIOACTS CO., LTD. (KR) | 2017-11-02 | — | — | US | disclosed |
| US-20160356681-A1 | MODIFIED CARBOCYANINE DYES AND THEIR CONJUGATES | Life Technologies Corporation | 2016-12-08 | — | — | US | disclosed |
| US-9423323-B2 | Modified carbocyanine dyes and their conjugates | Life Technologies Corporation (US) | 2016-08-23 | — | — | US | disclosed |
| US-9423323-B2 | Modified carbocyanine dyes and their conjugates | Life Technologies Corporation (US) | 2016-08-23 | — | — | US | disclosed |
| US-6977305-B2 | Modified carbocyanine dyes and their conjugates | MOLECULAR PROBES, INC. (US) | 2005-12-20 | — | — | US | disclosed |
| US-6974873-B2 | Modified carbocyanine dyes and their conjugates | MOLECULAR PROBES, INC. (US) | 2005-12-13 | — | — | US | disclosed |
| US-20050202565-A1 | Luminescent compounds | SETA BIOMEDICALS, LLC | 2005-09-15 | — | — | US | disclosed |
| EP-1525265-A4 | CHIRAL INDOLE INTERMEDIATES AND THEIR FLUORESCENT CYANINE DYES CONTAINING FUNCTIONAL GROUPS | UNIV CARNEGIE MELLON (US) | 2005-06-22 | — | — | EP | disclosed |
| EP-1525265-A2 | CHIRAL INDOLE INTERMEDIATES AND THEIR FLUORESCENT CYANINE DYES CONTAINING FUNCTIONAL GROUPS | CARNEGIE-MELLON UNIVERSITY (US) | 2005-04-27 | — | — | EP | disclosed |
| WO-2004039894-A2 | CHIRAL INDOLE INTERMEDIATES AND THEIR FLUORESCENT CYANINE DYES CONTAINING FUNCTIONAL GROUPS | CARNEGIE MELLON UNIVERSITY (US) | 2004-05-13 | — | — | WO | disclosed |
| EP-1322710-A1 | MODIFIED CARBOCYANINE DYES AND THEIR CONJUGATES | Molecular Probes Inc. (US) | 2003-07-02 | — | — | EP | disclosed |
| US-20020077487-A1 | Modified carbocyanine dyes and their conjugates | MOLECULAR PROBES, INC. | 2002-06-20 | — | — | US | disclosed |
| US-20020064794-A1 | Modified carbocyanine dyes and their conjugates | MOLECULAR PROBES, INC. | 2002-05-30 | — | — | US | disclosed |
| WO-2002026891-A1 | MODIFIED CARBOCYANINE DYES AND THEIR CONJUGATES | MOLECULAR PROBES, INC. (US) | 2002-04-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020077487-A1 | Modified carbocyanine dyes and their conjugates | IK, CBR3, DRD5 | ALDH1A1 385/4885TBXA2R 3668/4885CYP26B1 1410/4885 |
| US-20070178511-A1 | MODIFIED CARBOCYANINE DYES AND THEIR CONJUGATES | IK, CBR3, DRD5 | ALDH1A1 385/4885TBXA2R 3668/4885CYP26B1 1410/4885 |
| US-20230270890-A1 | FLUORESCENT COMPOUND FOR DETECTING BIOLOGICAL MATERIAL AND PREPARATION METHOD THEREOF | F12, MRGPRX4, C3AR1 | ALDH1A1 2502/4885TBXA2R 1733/4885CYP26B1 1420/4885 |
| US-20160356681-A1 | MODIFIED CARBOCYANINE DYES AND THEIR CONJUGATES | IK, CBR3, DRD5 | ALDH1A1 385/4885TBXA2R 3668/4885CYP26B1 1410/4885 |
| US-20170313883-A1 | FLUORESCENCE COMPOUNDS AND PREPARATION METHOD THEREOF | CDY1; CDY1B, CYP2F1, CYP4F11 | ALDH1A1 180/4885TBXA2R 565/4885CYP26B1 318/4885 |
| US-10294204-B2 | Fluorescence compounds and preparation method thereof | CDY1; CDY1B, CYP2F1, CYP4F11 | ALDH1A1 180/4885TBXA2R 565/4885CYP26B1 318/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.